Who Supplies Bleomycin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Bleomycin exports, with 206+ registered manufacturers shipping to buyers across 119+ countries — yet a handful of companies dominate the shipments. VENUS REMEDIES LIMITED holds the largest share at 7.4% (export value: $414.6K). Close behind, INFUGEN PHARMA PRIVATE LIMITED (7.3%, $404.6K). SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED (4.9%, $273.1K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Bleomycin? Top Manufacturers & Their Buyers
Flow of Bleomycin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Bleomycin Supplier Network — Key Market Intelligence
The Bleomycin export market from India is led by VENUS REMEDIES LIMITED, which alone commands a 7.4% share, shipping $414.6K worth of product across 134 shipments. The second-largest exporter, INFUGEN PHARMA PRIVATE LIMITED, contributes $404.6K (7.3%) to the overall market. Combined, the top two suppliers alone account for 14.7% of all Bleomycin exports, indicating a relatively concentrated supply base.
Across all 206 tracked manufacturers, the total Bleomycin export value stands at $5.6M from 1.1K shipments. The market average shipment value is $5.1K. The single largest buyer relationship in terms of trade value is CENTRAL DE MEDICAMENTOS E ARTIGOS., receiving $404.6K worth of product.
The combined buyer network spans 16 named purchasing companies, including E P H K, A S A S, V P G, F X S, PHARMACENTER HUNGARY KFT. and 11 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1VENUS REMEDIES LIMITED
VENUS REMEDIES LIMITED is the first-largest Bleomycin exporter from India, with a market share of 7.4% and a total export value of $414.6K across 134 shipments. Their average shipment value of $3.1K is below the market average of $5.1K, reflecting a high-volume, competitive pricing strategy.
VENUS REMEDIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• E P H K — $124.9K across 40 shipments (30.1% of this supplier's total exports)
• A S A S — $96.5K across 31 shipments (23.3% of this supplier's total exports)
• V P G — $75.8K across 25 shipments (18.3% of this supplier's total exports)
• F X S — $63.1K across 20 shipments (15.2% of this supplier's total exports)
• PHARMACENTER HUNGARY KFT. — $54.3K across 18 shipments (13.1% of this supplier's total exports)
Key Insight: VENUS REMEDIES LIMITED operates with high shipment frequency (134 shipments) at a per-shipment value of $3.1K, indicating a broad distribution network with many smaller, regular orders.
2INFUGEN PHARMA PRIVATE LIMITED
INFUGEN PHARMA PRIVATE LIMITED is the second-largest Bleomycin exporter from India, with a market share of 7.3% and a total export value of $404.6K across 6 shipments. Their average shipment value of $67.4K is above the market average of $5.1K, suggesting premium or bulk contract pricing.
INFUGEN PHARMA PRIVATE LIMITED serves 1 named buyer in our database. CENTRAL DE MEDICAMENTOS E ARTIGOS. is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• CENTRAL DE MEDICAMENTOS E ARTIGOS. — $404.6K across 6 shipments (100.0% of this supplier's total exports)
Key Insight: INFUGEN PHARMA PRIVATE LIMITED's per-shipment value of $67.4K is 1233% above the market average of $5.1K, consistent with large-order contracts or value-added formulations.
3SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED
SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED is the third-largest Bleomycin exporter from India, with a market share of 4.9% and a total export value of $273.1K across 6 shipments. Their average shipment value of $45.5K is above the market average of $5.1K, suggesting premium or bulk contract pricing.
SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED serves 2 named buyers in our database. BIOSISTEMAS Y SEGURIDAD PRIVADA SA is the dominant customer, accounting for 99.8% of this supplier's tracked business. Top customers include:
• BIOSISTEMAS Y SEGURIDAD PRIVADA SA — $272.6K across 6 shipments (99.8% of this supplier's total exports)
• ATLAS TRADING COMPAN — $522 across 0 shipments (0.2% of this supplier's total exports)
Key Insight: SEATRACK INTERNATIONAL TRADEX PRIVATE LIMITED's per-shipment value of $45.5K is 800% above the market average of $5.1K, consistent with large-order contracts or value-added formulations.
4NV REMEDIES PRIVATE LIMITED
NV REMEDIES PRIVATE LIMITED is the fourth-largest Bleomycin exporter from India, with a market share of 4.3% and a total export value of $236.7K across 12 shipments. Their average shipment value of $19.7K is above the market average of $5.1K, suggesting premium or bulk contract pricing.
NV REMEDIES PRIVATE LIMITED serves 4 named buyers in our database. CPC "BIOCON" LLC is the dominant customer, accounting for 99.6% of this supplier's tracked business. Top customers include:
• CPC "BIOCON" LLC — $235.7K across 12 shipments (99.6% of this supplier's total exports)
• KYRGYZPHARMACY — $983 across 0 shipments (0.4% of this supplier's total exports)
• MILI HEALTHCARE LTD — $2 across 0 shipments (0.0% of this supplier's total exports)
• MILI HEALTHCARE LIMI — $2 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: NV REMEDIES PRIVATE LIMITED's per-shipment value of $19.7K is 290% above the market average of $5.1K, consistent with large-order contracts or value-added formulations.
5NAPROD LIFE SCIENCES PRIVATE LIMITED
NAPROD LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Bleomycin exporter from India, with a market share of 3.7% and a total export value of $205.5K across 13 shipments. Their average shipment value of $15.8K is above the market average of $5.1K, suggesting premium or bulk contract pricing.
NAPROD LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MEDPRO PHARMACEUTICA (PTY) LTD — $76.8K across 5 shipments (37.4% of this supplier's total exports)
• CIPLA DISTRIBUTION G — $72.8K across 5 shipments (35.4% of this supplier's total exports)
• NATIONAL AIDS COUNCI — $20.5K across 1 shipments (10.0% of this supplier's total exports)
• SEVEN PHARMA S.A.C — $17.7K across 1 shipments (8.6% of this supplier's total exports)
• SEVEN PHARMA S.A.C — $17.7K across 1 shipments (8.6% of this supplier's total exports)
Key Insight: NAPROD LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $15.8K is 212% above the market average of $5.1K, consistent with large-order contracts or value-added formulations.
6VIVALIA REMEDIES PRIVATE LIMITED
VIVALIA REMEDIES PRIVATE LIMITED is the fifth-largest Bleomycin exporter from India, with a market share of 0.0% and a total export value of $0 across 4 shipments. Their average shipment value of $0 is below the market average of $5.1K, reflecting a high-volume, competitive pricing strategy.
Key Insight: VIVALIA REMEDIES PRIVATE LIMITED operates with high shipment frequency (4 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Bleomycin Flows
Once Bleomycin leaves the manufacturing plants of companies like VENUS REMEDIES LIMITED and INFUGEN PHARMA PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $5.6M. South Africa absorbs the largest share at 9.9% ($554.0K), followed by Mozambique (9.9%) and Uzbekistan (6.3%).
In South Africa — the top destination — named importers include MEDPRO PHARMACEUTICA (PTY) LTD. In Mozambique, key buyers are CENTRAL DE MEDICAMENTOS E ARTIGOS..
This geographic spread reflects Bleomycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Bleomycin Go? Top Importing Countries & Their Buyers
Trade flow of Bleomycin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1South Africa
South Africa ranks as the first-largest destination for Bleomycin imports from India, with a total trade value of $554.0K across 3 shipments — representing a 9.9% share of all Bleomycin exports. The average shipment value of $184.7K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bleomycin importers in South Africa: MEDPRO PHARMACEUTICA (PTY) LTD is the largest buyer, accounting for 45.5% ($252.1K) of this market's total imports.
• MEDPRO PHARMACEUTICA (PTY) LTD — $252.1K (45.5% of South Africa's total)
Key Insight: South Africa's per-shipment average of $184.7K (3551% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Bleomycin imports from India.
2Mozambique
Mozambique ranks as the second-largest destination for Bleomycin imports from India, with a total trade value of $548.9K across 6 shipments — representing a 9.9% share of all Bleomycin exports. The average shipment value of $91.5K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bleomycin importers in Mozambique: CENTRAL DE MEDICAMENTOS E ARTIGOS. is the largest buyer, accounting for 73.7% ($404.6K) of this market's total imports.
• CENTRAL DE MEDICAMENTOS E ARTIGOS. — $404.6K (73.7% of Mozambique's total)
Key Insight: Mozambique's per-shipment average of $91.5K (1709% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mozambique is a key market for Bleomycin imports from India.
3Uzbekistan
Uzbekistan ranks as the third-largest destination for Bleomycin imports from India, with a total trade value of $351.9K across 3 shipments — representing a 6.3% share of all Bleomycin exports. The average shipment value of $117.3K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bleomycin importers in Uzbekistan: VEF SAU is the largest buyer, accounting for 74.9% ($263.5K) of this market's total imports.
• VEF SAU — $263.5K (74.9% of Uzbekistan's total)
Key Insight: Uzbekistan's per-shipment average of $117.3K (2219% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Uzbekistan is a key market for Bleomycin imports from India.
4Mexico
Mexico ranks as the fourth-largest destination for Bleomycin imports from India, with a total trade value of $346.6K across 4 shipments — representing a 6.2% share of all Bleomycin exports. The average shipment value of $86.7K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Bleomycin importers in Mexico: BIOSISTEMAS Y SEGURIDAD PRIVADA SA is the largest buyer, accounting for 78.6% ($272.6K) of this market's total imports.
• BIOSISTEMAS Y SEGURIDAD PRIVADA SA — $272.6K (78.6% of Mexico's total)
Key Insight: Mexico's per-shipment average of $86.7K (1613% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Mexico is a key market for Bleomycin imports from India.
5Colombia
Colombia ranks as the fifth-largest destination for Bleomycin imports from India, with a total trade value of $345.7K across 17 shipments — representing a 6.2% share of all Bleomycin exports. The average shipment value of $20.3K is above the global average of $5.1K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Bleomycin importers in Colombia: ALPHARMA S.A.S. is the largest buyer, accounting for 43.6% ($150.7K) of this market's total imports.
• ALPHARMA S.A.S. — $150.7K (43.6% of Colombia's total)
• A S A S — $96.5K (27.9% of Colombia's total)
Key Insight: Colombia's per-shipment average of $20.3K (302% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Colombia is a key market for Bleomycin imports from India.
People Also Ask — Bleomycin Supplier & Trade Network
Who are the top suppliers of Bleomycin from India?+
Which companies buy Bleomycin from Indian manufacturers?+
Where does Bleomycin exported from India go?+
What is the market share of the top Bleomycin supplier from India?+
What is the average shipment value for Bleomycin exports from India?+
Is Bleomycin manufactured in India and exported globally?+
Which country imports the most Bleomycin from India?+
Who are the buyers of Bleomycin in Mozambique?+
How concentrated is the Bleomycin supplier market in India?+
How do I find verified buyers for Bleomycin in specific countries?+
Bleomycin Trade Network — Key Takeaways
- 1VENUS REMEDIES LIMITED is India's dominant Bleomycin exporter with a 7.4% market share and $414.6K in total exports — making it the single most important sourcing entity in this market.
- 2The top 206 suppliers collectively account for 27.6% of all tracked Bleomycin exports, with a combined trade value of $5.6M.
- 3South Africa is the largest destination market, absorbing 9.9% of India's Bleomycin exports ($554.0K). Mozambique (9.9%) and Uzbekistan (6.3%) follow.
- 4With 1.1K total shipments averaging $5.1K each, the Bleomycin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include E P H K, A S A S, CENTRAL DE MEDICAMENTOS E ARTIGOS., BIOSISTEMAS Y SEGURIDAD PRIVADA SA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 119 countries
Network value: $5.6M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bleomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Bleomycin.
- 2.Flow Mapping: 206 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,101 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 119 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,101 Verified Shipments
206 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists